Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izad168 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Jurij Hanzel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, United States Food and Drug Administration, Drug Approval. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia.
- Alimentiv Inc, London, ON, Canada.
- Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
- Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
- Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
- Independent statistical consultant, London, ON, Canada.
ORCID-Profile: Jurij Hanzel, Christopher Ma, Eileen Crowley, Siddharth Singh, Vipul Jairath
Zitieren
APA
Hanzel, J., Ma, C., De Silva, T. A., Alphonsus, L., Guizzetti, L., Crowley, E., Singh, S., & Jairath, V. (2024). Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad168
Vancouver
Hanzel J, Ma C, De Silva TA, Alphonsus L, Guizzetti L, Crowley E, et al. Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad168
BibTeX
@article{Hanzel2024,
author = {Hanzel, Jurij and Ma, Christopher and De Silva, Theshani Amalka and Alphonsus, Lotus and Guizzetti, Leonardo and Crowley, Eileen and Singh, Siddharth and Jairath, Vipul},
title = {Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izad168}
}
EUVIMED